Carly Barnett

1.0k total citations · 1 hit paper
9 papers, 644 citations indexed

About

Carly Barnett is a scholar working on Rheumatology, Nephrology and Pharmacology. According to data from OpenAlex, Carly Barnett has authored 9 papers receiving a total of 644 indexed citations (citations by other indexed papers that have themselves been cited), including 3 papers in Rheumatology, 2 papers in Nephrology and 2 papers in Pharmacology. Recurrent topics in Carly Barnett's work include Systemic Lupus Erythematosus Research (3 papers), Alzheimer's disease research and treatments (2 papers) and Dementia and Cognitive Impairment Research (2 papers). Carly Barnett is often cited by papers focused on Systemic Lupus Erythematosus Research (3 papers), Alzheimer's disease research and treatments (2 papers) and Dementia and Cognitive Impairment Research (2 papers). Carly Barnett collaborates with scholars based in United Kingdom, United States and Netherlands. Carly Barnett's co-authors include C. Kleoudis, Zahir Amoura, Susan W. Burriss, Y K Onno Teng, David A. Roth, Brad H. Rovin, Richard Furie, Ana Malvar, Beulah Ji and Gabriel Contreras and has published in prestigious journals such as New England Journal of Medicine, Annals of the Rheumatic Diseases and Nephrology Dialysis Transplantation.

In The Last Decade

Carly Barnett

9 papers receiving 633 citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Two-Year, Randomized, Controlled Trial of Belimumab in Lupus Nephritis

2020 549 citations Richard Furie, Brad H. Rovin et al. New England Journal of Medicine profile →

Peers

Carly Barnett

RHEUM

IMMUN

NEPHR

RNMI

HEPAT

Robert S Flanc Australia

K. I. Welsh United Kingdom

Claudia de Toma France

F. Pontillon France

Suzanne Krishfield United States

Sahoko Morinobu Japan

Yune‐Jung Park South Korea

Lisa Seitz United States

Yiming Shi China

Natalia Duque Spain

Robert S Flanc Australia

Carly Barnett

318 ×0.7

RHEUM

146 ×0.5

IMMUN

309 ×1.7

NEPHR

56 ×0.3

RNMI

118 ×1.5

HEPAT

Citations per year, relative to Carly Barnett Carly Barnett (= 1×) peers Robert S Flanc

Countries citing papers authored by Carly Barnett

Since Specialization

Citations

This map shows the geographic impact of Carly Barnett's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Carly Barnett with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Carly Barnett more than expected).

Fields of papers citing papers by Carly Barnett

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Carly Barnett. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Carly Barnett. The network helps show where Carly Barnett may publish in the future.

Co-authorship network of co-authors of Carly Barnett

This figure shows the co-authorship network connecting the top 25 collaborators of Carly Barnett. A scholar is included among the top collaborators of Carly Barnett based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Carly Barnett. Carly Barnett is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

9 of 9 papers shown

1.

Tipple, Craig, Naiem Moiemen, Christos V. Ioannou, et al.. (2020). Intestinal permeability in participants with thermal injury: A case series from a prospective, longitudinal study (HESTIA). Burns Open. 4(3). 94–102. 1 indexed citations

2.

Furie, Richard, Brad H. Rovin, Frédéric Houssiau, et al.. (2020). Two-Year, Randomized, Controlled Trial of Belimumab in Lupus Nephritis. New England Journal of Medicine. 383(12). 1117–1128. 549 indexed citations breakdown →

3.

Furie, Richard, Brad H. Rovin, F. Houssiau, et al.. (2020). OP0164 BLISS-LN: A RANDOMISED, DOUBLE-BLIND, PLACEBO-CONTROLLED PHASE 3 TRIAL OF INTRAVENOUS BELIMUMAB IN PATIENTS WITH ACTIVE LUPUS NEPHRITIS. Annals of the Rheumatic Diseases. 79. 103–103. 11 indexed citations

4.

Rovin, Brad H., Frédéric Houssiau, Richard Furie, et al.. (2020). LB001EFFICACY AND SAFETY OF BELIMUMAB IN PATIENTS WITH ACTIVE LUPUS NEPHRITIS: A PHASE 3, RANDOMISED, PLACEBO-CONTROLLED TRIAL. Nephrology Dialysis Transplantation. 35(Supplement_3). 2 indexed citations

5.

Maher‐Edwards, Gareth, et al.. (2015). A 24‐week study to evaluate the effect of rilapladib on cognition and cerebrospinal fluid biomarkers of Alzheimer's disease. Alzheimer s & Dementia Translational Research & Clinical Interventions. 1(2). 131–140. 35 indexed citations

6.

Cuffe, Robert L., Carly Barnett, Catherine Granier, et al.. (2015). Missing CD4+ cell response in randomized clinical trials of maraviroc and dolutegravir. HIV Clinical Trials. 16(5). 170–177. 1 indexed citations

7.

Maher‐Edwards, Gareth, Carolyn Watson, John A. Ascher, et al.. (2015). Two randomized controlled trials of SB742457 in mild‐to‐moderate Alzheimer's disease. Alzheimer s & Dementia Translational Research & Clinical Interventions. 1(1). 23–36. 42 indexed citations

8.

Maher‐Edwards, Gareth, et al.. (2014). A 24‐WEEK STUDY TO EVALUATE THE EFFECT OF RILAPLADIB ON COGNITION AND CSF MARKERS OF ALZHEIMER'S DISEASE. Alzheimer s & Dementia. 10(4S_Part_5). 1 indexed citations

9.

Manca, Donna, et al.. (2009). Who is driving continuing medical education for family medicine?. Journal of Continuing Education in the Health Professions. 29(1). 63–67. 2 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact